MYELOPROLIFERATIVE NEOPLASM (MPN)
Clinical trials for MYELOPROLIFERATIVE NEOPLASM (MPN) explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM (MPN) trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM (MPN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant cocktail aims to tame blood cancer without severe side effects
Disease control Recruiting nowThis early-stage trial is testing a new combination of chemotherapy drugs (thiotepa, busulfan, and fludarabine) followed by a stem cell transplant for people with certain blood cancers like leukemia and myelodysplastic syndrome. The goal is to see if this approach can reduce the …
Matched conditions: MYELOPROLIFERATIVE NEOPLASM (MPN)
Phase: PHASE1 • Sponsor: Sawa Ito, MD • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC
-
New drug cocktails aim to tame transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests whether new drug combinations can better prevent graft-versus-host disease (GVHD) in people with blood cancers who receive a stem cell transplant from a mismatched unrelated donor. About 358 participants will get either the standard GVHD prevention or one of two …
Matched conditions: MYELOPROLIFERATIVE NEOPLASM (MPN)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Scientists hunt for immune cells that could lead to new MPN therapies
Knowledge-focused Recruiting nowThis study looks at how the immune system reacts to myeloproliferative neoplasms (MPN), a group of blood cancers. Researchers will collect blood and bone marrow samples from 150 adults with or without MPN to find special immune cells (T cells) that recognize and attack MPN cells.…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM (MPN)
Sponsor: Université Catholique de Louvain • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC